Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure. [electronic resource]
Producer: 19990419Description: 1174-81 p. digitalISSN:- 0735-1097
- Adolescent
- Adult
- Angiotensin Receptor Antagonists
- Antihypertensive Agents -- administration & dosage
- Biphenyl Compounds -- administration & dosage
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Heart Failure -- blood
- Hemodynamics -- drug effects
- Humans
- Irbesartan
- Male
- Middle Aged
- Norepinephrine -- blood
- Receptor, Angiotensin, Type 1
- Receptor, Angiotensin, Type 2
- Safety
- Single-Blind Method
- Tetrazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.